Nomura Securities Starts Biogen (BIIB) at Buy, $368 PT
Tweet Send to a Friend
Nomura Securities initiates coverage on Biogen (NASDAQ: BIIB) with a Buy. PT $368.00.
"We believe Biogen offers investors a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
"We believe Biogen offers investors a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
